Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
SegawaYHashimotoHMaruyamaSShintaniMOhnoHNakaiYet al
Lawsuits allege that drug manufacturers failed to warn prescribing physicians and patients of the risk of kidney damage, leaving patients vulnerable to severe health issues
Evidence Level [EL] 1)
Clinical implications Patients with T2DM and AF have higher mortality rates and cardiovascular complications than those in sinus rhythm, with thromboembolism being the most significant risk factor [2]
But investors werent impressed
US$ 25.47
US$ 29.39
US$ 22.32
US$ 29.91
US$ 29.25
